The European Innovation Council (EIC) Jury of independent experts awarded Edvince “GO” which implies that Edvince is set to receive a 2.5 mio EUR grant for the clinical study with EDV2209 in subarachnoid haemorrhage (SAH).

https://eic.ec.europa.eu/news/largest-ever-funding-round-european-innovation-council-accelerator-99-innovative-companies-set-2021-12-16_en